Our findings that primary adipocytes express both fpr1 and fpr2, and direct addition of WKYMVm into primary adipocytes effectively modulates the expression of genes in lipid metabolism suggest that WKYMVm may act on primary adipocytes, resulting in the improvement of lipid metabolism in obesity. The gene discussed is FPR2; the disease is obesity disorder.